Healthcare has a $20B “Super” Problem: Precision Medicine is Here to Cut Costs and Save Lives
In recent years, biotech, pharmaceutical and healthcare executives have been dealing with a global crisis created by the prevalence of multi-drug resistant organisms (MDROs), or as they have come to be referred to more commonly, superbugs. The Centers for Disease Control and Prevention (CDC) estimates that antibiotic-resistant infections are responsible for two million illnesses and 23,000 deaths annually in the U.S. alone. These infections are not only widespread, they can be costly and challenging as many healthcare facilities lack access…
You might be interested in
